Home > Healthcare > Biotechnology > Biotechnology R&D > Mesenchymal Stem Cells Market

Mesenchymal Stem Cells Market Share

  • Report ID: GMI6555
  • Published Date: Aug 2023
  • Report Format: PDF

Mesenchymal Stem Cells Market Share

Major market players operating in the mesenchymal stem cells market

  • Thermo Fisher Scientific, Inc.
  • Cell Applications, Inc.
  • Cyagen Biosciences
  • Lonza
  • PromoCell GmbH 
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for mesenchymal stem cells accounted for USD 3 billion in 2022 and is estimated to grow at 12.8% CAGR from 2023 to 2032, backed by the rising prevalence of chronic diseases such as cancer, autoimmune disease, diabetes, and others.

The products segment accounted for 76.8% of the market share in 2022 and is projected to witness robust growth through 2032. Products like kits and reagents designed for mesenchymal stem cells research streamline experimental processes, ensuring accuracy and reproducibility.

North America market accounted for 42.4% revenu share in 2022 and is anticipated to grow at considerable growth rate owing to robust research infrastructure coupled with a strong emphasis on medical innovation, leading to a thriving MSC-related advancements.

Thermo Fisher Scientific, Inc., Cell Applications, Inc., Cyagen Biosciences, Lonza, PromoCell GmbH among others.

Mesenchymal Stem Cells Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 391
  • Countries covered: 19
  • Pages: 180
 Download Free Sample